What is it about?
Allergic conjunctivitis (AC) is one of the most common ocular diseases in the world. T-helper type 2 (Th2) immune responses play a central role in eliciting AC. In addition to Th2 cytokines and chemokines, the levels of various pro-inflammatory lipid mediators released by mast cells and eosinophils also increase in the conjunctiva with AC. However, eye drops currently used to treat AC, such as those containing anti-histamine, glucocorticoid, or immunosuppressive drugs, do not target these lipid mediators. In this study, we found that dietary omega-3 fatty acids alleviate AC by reducing pro-inflammatory lipid mediators without modulating Th2 immune responses. Our findings provide evidence that eating food rich in omega-3 fatty acids is a convenient and practical strategy for treating AC.
Featured Image
Read the Original
This page is a summary of: Dietary omega-3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating Th2 immune responses, The FASEB Journal, November 2018, Federation of American Societies For Experimental Biology (FASEB),
DOI: 10.1096/fj.201801805r.
You can read the full text:
Contributors
The following have contributed to this page







